Clinical trial
A Study for Participants With Spinal Muscular Atrophy (SMA) Who Previously…
NCT02594124 · Biogen, Industry · Completed
Key facts
| NCT number | NCT02594124 |
|---|---|
| Title | A Study for Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in Nusinersen (ISIS 396443) Investigational Studies |
| Official title | An Open-Label Extension Study for Patients With Spinal Muscular Atrophy Who Previously Participated in Investigational Studies of ISIS 396443 |
| Acronym | SHINE |
| Lead sponsor | Biogen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Spinal Muscular Atrophy |
| Intervention type | Drug |
| Interventions | nusinersen |
| Enrollment | 292 |
| Start date | Nov 4, 2015 |
| Primary completion | Aug 21, 2023 |
| Completion | Aug 21, 2023 |
| First posted | Nov 2, 2015 |
| Last update posted | Oct 22, 2024 |
| Countries | Australia, Belgium, Canada, France, Germany, Hong Kong, Italy, Japan, South Korea, Spain, Sweden, Turkey (Türkiye) and 2 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: